A leader in precision radiation medicine, Elekta is committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. 

Visit the Elekta site: elekta.com 

Follow @Elekta on Twitter, Facebook and LinkedIn